NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Orthofix Medical Inc (NASDAQ:OFIX) posted its quarterly earnings results on Monday, October, 28th. The medical device company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.51 by $0.10. The medical device company had revenue of $113.50 million for the quarter, compared to analyst estimates of $117.83 million. Orthofix Medical had a negative net margin of 6.81% and a positive return on equity of 9.16%. The firm's quarterly revenue was up 1.6% on a year-over-year basis. During the same period in the previous year, the firm posted $0.44 earnings per share. View Orthofix Medical's Earnings History.

Orthofix Medical is scheduled to release their next quarterly earnings announcement on Monday, February 24th 2020. View Earnings Estimates for Orthofix Medical.

2 analysts have issued 1 year price targets for Orthofix Medical's shares. Their forecasts range from $48.00 to $48.00. On average, they expect Orthofix Medical's stock price to reach $48.00 in the next twelve months. This suggests a possible upside of 6.7% from the stock's current price. View Analyst Price Targets for Orthofix Medical.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Orthofix Medical.

News stories about OFIX stock have trended somewhat negative recently, InfoTrie reports. The research firm scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Orthofix Medical earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news coverage about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Orthofix Medical.

Orthofix Medical saw a decline in short interest in the month of January. As of January 15th, there was short interest totalling 371,800 shares, a decline of 13.7% from the December 31st total of 431,000 shares. Based on an average daily volume of 142,500 shares, the days-to-cover ratio is currently 2.6 days. Currently, 2.0% of the company's stock are sold short. View Orthofix Medical's Current Options Chain.

Some companies that are related to Orthofix Medical include Medtronic (MDT), Abbott Laboratories (ABT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Edwards Lifesciences (EW), Baxter International (BAX), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Teleflex (TFX), Hologic (HOLX), Varian Medical Systems (VAR) and Steris (STE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL), Zogenix (ZGNX) and Allergan (AGN).

Orthofix Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (2.23%), State of Alaska Department of Revenue (0.08%), New York State Teachers Retirement System (0.05%) and Louisiana State Employees Retirement System (0.03%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix Medical.

OFIX stock was sold by a variety of institutional investors in the last quarter, including Louisiana State Employees Retirement System, New York State Teachers Retirement System and State of Alaska Department of Revenue. Company insiders that have sold Orthofix Medical company stock in the last year include Brad Mason and Davide Bianchi. View Insider Buying and Selling for Orthofix Medical.

OFIX stock was acquired by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. View Insider Buying and Selling for Orthofix Medical.

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of OFIX stock can currently be purchased for approximately $45.00.

Orthofix Medical has a market capitalization of $857.70 million and generates $453.04 million in revenue each year. The medical device company earns $13.81 million in net income (profit) each year or $1.96 on an earnings per share basis. Orthofix Medical employs 954 workers across the globe.View Additional Information About Orthofix Medical.

The official website for Orthofix Medical is http://www.orthofix.com/.

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected].